…first cancer therapy using red blood cells. We talked to the CEO, Gil Beyen, to find out how the technology works and what it could mean for the treatment of…
…to restore the damaged joints. “Stem cells are very useful if you can put them in the right environment. But if they’re in an environment that’s sort of unfriendly, they’re…
…small molecule therapies, which is that they could be better at getting rid of the old cells without harming the healthy cells, given the right target. “One of the Holy…
…a clinical drug that sensitizes glioblastoma cells to radiotherapy and could replace temozolomide. Post-surgical radiotherapy and temozolomide, a chemotherapeutic drug, targeting post-cell division is the current standard of care for…
…that can be used to test treatments for neuropsychiatric disorders. The organoids are designed to carry out high-throughput screening of drugs targeting the central nervous system (CNS). It merges cell…
…of cancer that affects the cells responsible for protecting our body against infections. Unlike it’s done with cancer types that affect other blood cells, it’s not possible to just wipe…
…the tumor cells. If the mRNA enters non-target cells lacking these signatures, it is designed to self-destruct, thereby preventing unintended protein expression in healthy tissues. Strand’s lead investigational therapy, STX-001,…
…the treatment. This will cause recurrence that is strongly connected to increased mortality. That certain cancer cells can avoid treatment suggests there are biologic factors inside cancer cells that can…
…half of 2026, and could still validate the drug’s potential. While these developments do represent a significant setback for the company, let’s not bury the treatment yet and wait and…
…the therapy. Mike Leek, CEO of TC Biopharm, believes that thanks to this strategy the company has the potential to address two key areas. The first is solid tumors, which…
…common indications (such as the uniQure/BMS deal for congestive heart failure), will gene therapy trials get bigger? Can CAP-GT follow that trend? Yes, we foresee that the trials will get…
…but it was discovered that it also encourages cells of the immune system to grow and become active in the bladder lining, therefore, making it effective against bladder cancer. It…